Foamix Pharmaceuticals Ltd. Interest Expense, Long-term Debt
Foamix Pharmaceuticals Ltd. reported Interest Expense, Long-term Debt of $921.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseLongTermDebt · last filed 2020-03-12
- Foamix Pharmaceuticals Ltd. interest expense, long-term debt for fiscal 2019 was $921.00K.
| Period end | Interest Expense, Long-term Debt 12 month |
|---|---|
| 2019-12-31 | $921.00K 10-K · filed 2020-03-12 |